Literature DB >> 29920352

IL-22 promotes allergic airway inflammation in epicutaneously sensitized mice.

Juan Manuel Leyva-Castillo1, Juhan Yoon1, Raif S Geha2.   

Abstract

BACKGROUND: Serum IL-22 levels are increased in patients with atopic dermatitis, which commonly precedes asthma in the atopic march. Epicutaneous sensitization in mice results in TH2-dominated skin inflammation that mimics atopic dermatitis and sensitizes the airways for antigen challenge-induced allergic inflammation characterized by the presence of both eosinophils and neutrophils. Epicutaneous sensitization results in increased serum levels of IL-22.
OBJECTIVE: We sought to determine the role of IL-22 in antigen-driven airway allergic inflammation after inhalation challenge in epicutaneously sensitized mice.
METHODS: Wild-type (WT) and Il22-/- mice were sensitized epicutaneously or immunized intraperitoneally with ovalbumin (OVA) and challenged intranasally with antigen. OVA T-cell receptor-specific T cells were TH22 polarized in vitro. Airway inflammation, mRNA levels in the lungs, and airway hyperresponsiveness (AHR) were examined.
RESULTS: Epicutaneous sensitization preferentially elicited an IL-22 response compared with intraperitoneal immunization. Intranasal challenge of mice epicutaneously sensitized with OVA elicited in the lungs Il22 mRNA expression, IL-22 production, and accumulation of CD3+CD4+IL-22+ T cells that coexpressed IL-17A and TNF-α. Epicutaneously sensitized Il22-/- mice exhibited diminished eosinophil and neutrophil airway infiltration and decreased AHR after intranasal OVA challenge. Production of IL-13, IL-17A, and TNF-α was normal, but IFN-γ production was increased in lung cells from airway-challenged and epicutaneously sensitized Il22-/- mice. Intranasal instillation of IFN-γ-neutralizing antibody partially reversed the defect in eosinophil recruitment. WT recipients of TH22-polarized WT, but not IL-22-deficient, T-cell receptor OVA-specific T cells, which secrete both IL-17A and TNF-α, had neutrophil-dominated airway inflammation and AHR on intranasal OVA challenge. Intranasal instillation of IL-22 with TNF-α, but not IL-17A, elicited neutrophil-dominated airway inflammation and AHR in WT mice, suggesting that loss of IL-22 synergy with TNF-α contributed to defective recruitment of neutrophils into the airways of Il22-/- mice. TNF-α, but not IL-22, blockade at the time of antigen inhalation challenge inhibited airway inflammation in epicutaneously sensitized mice.
CONCLUSION: Epicutaneous sensitization promotes generation of antigen-specific IL-22-producing T cells that promote airway inflammation and AHR after antigen challenge, suggesting that IL-22 plays an important role in the atopic march.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL-22; asthma; atopic dermatitis; neutrophils

Mesh:

Substances:

Year:  2018        PMID: 29920352      PMCID: PMC6298864          DOI: 10.1016/j.jaci.2018.05.032

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  49 in total

1.  Aryl hydrocarbon receptor deficiency in T cells suppresses the development of collagen-induced arthritis.

Authors:  Taisuke Nakahama; Akihiro Kimura; Nam Trung Nguyen; Ichino Chinen; Hamza Hanieh; Keiko Nohara; Yoshiaki Fujii-Kuriyama; Tadamitsu Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

2.  The potential protective role of the combination of IL-22 and TNF-α against genital tract Chlamydia trachomatis infection.

Authors:  Xiumin Zhao; Danyang Zhu; Jiangbin Ye; Xingqun Li; Zhibin Wang; Lifang Zhang; Wen Xu
Journal:  Cytokine       Date:  2015-02-28       Impact factor: 3.861

3.  Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.

Authors:  J M Spergel; E Mizoguchi; J P Brewer; T R Martin; A K Bhan; R S Geha
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

4.  IFN-γ acts on the airway epithelium to inhibit local and systemic pathology in allergic airway disease.

Authors:  Charlotte Mitchell; Karin Provost; Naiqian Niu; Robert Homer; Lauren Cohn
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

5.  Interleukin-22 is a negative regulator of the allergic response.

Authors:  Bruno Schnyder; Carla Lima; Silvia Schnyder-Candrian
Journal:  Cytokine       Date:  2010-03-02       Impact factor: 3.861

6.  A role for Th17 cells in the immunopathogenesis of atopic dermatitis?

Authors:  Antonella Di Cesare; Paola Di Meglio; Frank O Nestle
Journal:  J Invest Dermatol       Date:  2008-11       Impact factor: 8.551

7.  TSLP produced by keratinocytes promotes allergen sensitization through skin and thereby triggers atopic march in mice.

Authors:  Juan Manuel Leyva-Castillo; Pierre Hener; Hua Jiang; Mei Li
Journal:  J Invest Dermatol       Date:  2012-07-26       Impact factor: 8.551

8.  ST2 regulates allergic airway inflammation and T-cell polarization in epicutaneously sensitized mice.

Authors:  Terhi Savinko; Piia Karisola; Sari Lehtimäki; Anna-Mari Lappeteläinen; Rita Haapakoski; Henrik Wolff; Antti Lauerma; Harri Alenius
Journal:  J Invest Dermatol       Date:  2013-04-30       Impact factor: 8.551

9.  IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis.

Authors:  Carlene L Zindl; Jen-Feng Lai; Yun Kyung Lee; Craig L Maynard; Stacey N Harbour; Wenjun Ouyang; David D Chaplin; Casey T Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-18       Impact factor: 11.205

10.  IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization.

Authors:  Juhan Yoon; Juan Manuel Leyva-Castillo; Guoxing Wang; Claire Galand; Michiko K Oyoshi; Lalit Kumar; Sabine Hoff; Rui He; Alexander Chervonsky; Joost J Oppenheim; Vijay K Kuchroo; Marcel R M van den Brink; Rene De Waal Malefyt; Philippe A Tessier; Robert Fuhlbrigge; Philip Rosenstiel; Cox Terhorst; George Murphy; Raif S Geha
Journal:  J Exp Med       Date:  2016-08-22       Impact factor: 14.307

View more
  18 in total

1.  Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma.

Authors:  Sabag D Adi; Nasren Eiza; Jacob Bejar; Hila Shefer; Shira Toledano; Ofra Kessler; Gera Neufeld; Elias Toubi; Zahava Vadasz
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

2.  IL-22 Plays a Dual Role in the Amniotic Cavity: Tissue Injury and Host Defense against Microbes in Preterm Labor.

Authors:  Meyer Gershater; Roberto Romero; Marcia Arenas-Hernandez; Jose Galaz; Kenichiro Motomura; Li Tao; Yi Xu; Derek Miller; Roger Pique-Regi; Gregorio Martinez; Yesong Liu; Eunjung Jung; Robert Para; Nardhy Gomez-Lopez
Journal:  J Immunol       Date:  2022-03-18       Impact factor: 5.422

3.  Single-cell transcriptome profile of mouse skin undergoing antigen-driven allergic inflammation recapitulates findings in atopic dermatitis skin lesions.

Authors:  Juan Manuel Leyva-Castillo; Liang Sun; Shih-Ying Wu; Shira Rockowitz; Piotr Sliz; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2022-03-15       Impact factor: 14.290

4.  IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling.

Authors:  Xiangrong Cui; Xuan Jing; Qin Yi; Zhongping Xiang; Jie Tian; Bin Tan; Jing Zhu
Journal:  Oncol Rep       Date:  2019-02-11       Impact factor: 3.906

5.  Role of IL-22 in persistent allergic airway diseases caused by house dust mite: a pilot study.

Authors:  Laura Tamasauskiene; Vilte Marija Gintauskiene; Daina Bastyte; Brigita Sitkauskiene
Journal:  BMC Pulm Med       Date:  2021-01-21       Impact factor: 3.317

6.  Atopic dermatitis trajectories to age 8 years in the GUSTO cohort.

Authors:  Noor H A Suaini; Gaik Chin Yap; Do Phuong Tung Bui; Evelyn Xiu Ling Loo; Anne Eng Neo Goh; Oon Hoe Teoh; Kok Hian Tan; Keith M Godfrey; Bee Wah Lee; Lynette Pei-Chi Shek; Hugo Van Bever; Yap Seng Chong; Elizabeth Huiwen Tham
Journal:  Clin Exp Allergy       Date:  2021-07-31       Impact factor: 5.018

7.  Enhanced Type 2 Immune Reactions by Increased IL-22/IL-22Ra1 Signaling in Chronic Rhinosinusitis With Nasal Polyps.

Authors:  Dong Kyu Kim; Ara Jo; Hee Suk Lim; Jin Youp Kim; Kyoung Mi Eun; Jayoung Oh; Joon Kon Kim; Seong Ho Cho; Dae Woo Kim
Journal:  Allergy Asthma Immunol Res       Date:  2020-11       Impact factor: 5.764

Review 8.  Airway Remodeling in Asthma.

Authors:  Kenneth P Hough; Miranda L Curtiss; Trevor J Blain; Rui-Ming Liu; Jennifer Trevor; Jessy S Deshane; Victor J Thannickal
Journal:  Front Med (Lausanne)       Date:  2020-05-21

Review 9.  A Double Edged Sword Role of Interleukin-22 in Wound Healing and Tissue Regeneration.

Authors:  Tanzeela Arshad; Fizzah Mansur; Richard Palek; Sobia Manzoor; Vaclav Liska
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

10.  IL-22 hinders antiviral T cell responses and exacerbates ZIKV encephalitis in immunocompetent neonatal mice.

Authors:  Yuejin Liang; Panpan Yi; Wenjuan Ru; Zuliang Jie; Hui Wang; Tamer Ghanayem; Xiaofang Wang; Edrous Alamer; Jinjun Liu; Haitao Hu; Lynn Soong; Jiyang Cai; Jiaren Sun
Journal:  J Neuroinflammation       Date:  2020-08-25       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.